AKAMON

This brand name is authorized in Cyprus, Hong Kong, Malta

Active ingredients

The drug AKAMON contains one active pharmaceutical ingredient (API):

1 Bromazepam UNII X015L14V0O - BROMAZEPAM

Bromazepam is a pyridylbenzodiazepine compound with anxiolytic properties. Read about Bromazepam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AKAMON Tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05BA08	Bromazepam	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 25345, 25346
Country: MT	Medicines Authority	Identifier(s): MA032/00101, MA032/00102